Insights

Innovative AI Solutions AKASA specializes in generative AI solutions tailored for healthcare revenue cycle management, providing a promising opportunity to address hospitals and health systems seeking cutting-edge technology to improve operational efficiency and financial performance.

Recent Product Launches The recent launch of AKASA CDI Optimizer and Medical Coding AI assistants indicates ongoing product innovation and expansion into critical revenue cycle areas, which can be leveraged to upsell or introduce tailored solutions to prospective clients involved in coding and documentation optimization.

Data-Driven Customization With proprietary AI trained on each health system’s own clinical and financial data, AKASA offers highly customized AI solutions, making it easier to pitch these offerings to organizations seeking bespoke automation tools to differentiate themselves.

Funding & Growth Potential Having raised over $200 million, AKASA demonstrates strong financial backing and growth momentum, suggesting a stable partnership environment and an expanding product ecosystem ideal for long-term collaborations and pilot programs.

Industry Focused Expertise The company’s focus on healthcare revenue cycles combined with their active participation in industry events like HFMA positions them as a knowledgeable partner, offering opportunities to align solutions with the specific needs of hospitals, health systems, and revenue cycle teams.

AKASA Tech Stack

AKASA uses 8 technology products and services including OpenSearch, OAuth, Asana, and more. Explore AKASA's tech stack below.

  • OpenSearch
    Analytics
  • OAuth
    Identity And Access Management
  • Asana
    Issue Trackers
  • SEMrush
    Marketing Automation
  • Go
    Programming Languages
  • Node.js
    Programming Languages
  • Ahrefs
    Search Marketing
  • Facebook
    Widgets

Media & News

AKASA's Email Address Formats

AKASA uses at least 1 format(s):
AKASA Email FormatsExamplePercentage
First.Last@akasa.comJohn.Doe@akasa.com
93%
First@akasa.comJohn@akasa.com
4%
FLast@akasa.comJDoe@akasa.com
2%
Last@akasa.comDoe@akasa.com
1%

Frequently Asked Questions

What is AKASA's stock symbol?

Minus sign iconPlus sign icon
AKASA is a publicly traded company; the company's stock symbol is 6022.T.

What is AKASA's official website and social media links?

Minus sign iconPlus sign icon
AKASA's official website is akasa.com and has social profiles on LinkedInCrunchbase.

What is AKASA's NAICS code?

Minus sign iconPlus sign icon
AKASA's NAICS code is 5112 - Software Publishers.

How many employees does AKASA have currently?

Minus sign iconPlus sign icon
As of December 2025, AKASA has approximately 213 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Chief Product Officer: C. C.Head Of Commercial Growth: R. T.Head Of Deployment: M. S.. Explore AKASA's employee directory with LeadIQ.

What industry does AKASA belong to?

Minus sign iconPlus sign icon
AKASA operates in the Software Development industry.

What technology does AKASA use?

Minus sign iconPlus sign icon
AKASA's tech stack includes OpenSearchOAuthAsanaSEMrushGoNode.jsAhrefsFacebook.

What is AKASA's email format?

Minus sign iconPlus sign icon
AKASA's email format typically follows the pattern of First.Last@akasa.com. Find more AKASA email formats with LeadIQ.

When was AKASA founded?

Minus sign iconPlus sign icon
AKASA was founded in 2019.

AKASA

Software DevelopmentCalifornia, United States201-500 Employees

Healthcare revenue cycle teams are strained. Volumes are rising, margins are constricting, and hiring and retaining enough staff is impossible. That’s why you need technology. It’s the only way things are going to get better. 

AKASA is the preeminent provider of generative AI solutions for the healthcare revenue cycle

Our offerings are built on the AKASA Platform, which integrates the company’s proprietary generative AI technology and deep revenue cycle expertise to deliver exceptional impact for hospitals, health systems, and the patients they serve. 

AKASA is the only AI company whose technology is trained on a health system’s own clinical and financial data, enabling AI to better understand the specific nuances of a health system. 

With investors including Andreessen Horowitz, BOND, Costanoa Ventures, and others, we’ve raised more than $200M to help eliminate the financial complexity of healthcare.

We’re rebuilding the healthcare revenue cycle with AI. Let’s chat.

Section iconCompany Overview

Website
akasa.com
Stock Symbol
6022.T
NAICS Code
5112 - Software Publishers
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.